CXCR inhibitor ATI-2341, Purity ≥98%

Cat. No.: X23-10-ZQ640

CXCR inhibitor ATI-2341, Purity ≥98%

Synonym: ATI-2341; 1337878-62-2; ATI 2341; ATI2341; HY-P0172; s8309; CXCR inhibitor

  • CAS Number: 1337878-62-2
  • Compound CID: 121513892
Product Size
1 mg; 2 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
ATI-2341, soluble in DMSO and ethanol and insoluble in water, targets the chemokine receptors CXCR, which are part of the GPCR family.
Molecular Weight
2256.82
Molecular Formula
C104H178N26O25S2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 85 mg/mL (37.66 mM); Water: Insoluble; Ethanol: 2 mg/mL (0.88 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
ATI-2341 is a chemokine receptor antagonist used to investigate the modulation of CXCR4 receptor activity, relevant in cancer metastasis and immune cell trafficking studies.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.